All Stories

  1. Cardiac Incidentalomas in the Trauma Bay
  2. Impact of Contour Boundary Offsets on 4D Flow CMR-Derived Intracardiac Haemodynamic Parameters
  3. Cardiovascular Magnetic Resonance in Contemporary Guidelines: Divergence Between ESC and NICE Across Major Cardiovascular Diseases
  4. Prognostic Value of Left Ventricular Kinetic Energy for Predicting Major Adverse Events in Hypertrophic Cardiomyopathy
  5. Determinants of image quality in transthoracic echocardiography: A retrospective cohort study
  6. Myocardial Viability and Ischaemia in Chronic Total Occlusion
  7. Biomimetic transcatheter aortic valve replacement restores ascending aortic flow towards native physiology: A first-in-human prospective imaging study
  8. The Added Value of 4D ‐Flow CMR : Identifying Aortic Regurgitation as the Culprit for Severe Cardiomyopathy
  9. Non-Invasive CMR Pulmonary Capillary Wedge Pressure Predicts Future Atrial Fibrillation: A LOOP Substudy
  10. Development and Validation of a Noninvasive Model of Mixed Venous Oxygen Saturation in Heart Failure
  11. Does CMR improve aetiological sub-phenotyping beyond echocardiography in patients with elevated LV filling pressure? A prospective registry study (PREFER-CMR)
  12. Right Heart Flow Haemodynamic Assessment using 4D Flow CMR: A Systematic Review
  13. The role of CMR in the timing of aortic valve interventions and risk stratification in aortic regurgitation: a systematic review and meta-analysis
  14. The Added Value of 4D-Flow CMR: Identifying Aortic Regurgitation as the Culprit for Severe Cardiomyopathy
  15. Clinical 4D flow MRI assessment in aortopathy—what the clinician needs to know
  16. Enhancing accuracy of detecting left atrial dilatation on CT pulmonary angiography
  17. Giant Hiatus Hernia Causing Pulmonary Vein Obstruction: Insights From 4D Flow Cardiac MRI
  18. Development and evaluation of an autism information pack for culturally and linguistically diverse families: a quality improvement initiative
  19. A fully automated explainable predictive model for diagnosing pre-capillary and post-capillary pulmonary hypertension on routine unenhanced CT: results from the ASPIRE registry
  20. DurAVR – a novel biomimetic balloon-expandable transcatheter valve for TAVI, valve-in-valve TAVI and redo-TAVI
  21. Pulmonary hypertension and the role of MRI flow assessment: a systematic review
  22. Haemodynamic implications of cardiovascular magnetic resonance pulmonary capillary wedge pressure in acute myocardial infarction
  23. Improving Access to Developmental Assessments Before School: Evaluation of Targeted ‘School Starter Blitz’ Clinics in Metropolitan Sydney
  24. CMR Left Ventricular Filling Pressure Exhibits Strong Haemodynamic Relevance and Outperforms Echocardiography in Multimodal Heart Failure Assessment
  25. A fully coupled fluid-structure interaction model for patient-specific analysis of bioprosthetic aortic valve haemodynamics
  26. Same disease, same benefit: CMR clarifies sex differences in mitral valve surgery
  27. Cardiovascular magnetic resonance imaging markers of ageing: a multi-centre, cross-sectional cohort study
  28. Dynamic Velocity Tracking in the Left‐Ventricular Outflow Track Using Four‐Dimensional 4D Flow for the Assessment of Left Ventricular Outflow Track Obstruction
  29. The systemic right ventricle: Is the tricuspid valve its “Achilles” heel’?
  30. Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure
  31. Cardiac MRI-derived mean right atrial pressure and its prognostic importance
  32. Four-dimensional flow provides incremental diagnostic value over echocardiography in aortic stenosis
  33. Human pressure-volume loops from the impedance catheter: Development and validation of semi-automated beat-by-beat analysis
  34. Cardiovascular magnetic resonance imaging in mitral valve disease
  35. How can Four-Dimensional Magnetic Resonance Imaging Improve the Diagnosis of Heart Disease?
  36. Estimating Coronary Sinus Oxygen Saturation from Pulmonary Artery Oxygen Saturation
  37. Automated Quantification of Simple and Complex Aortic Flow Using 2D Phase Contrast MRI
  38. Risk factors for raised left ventricular filling pressure by cardiovascular magnetic resonance: Prognostic insights
  39. Clinical relevance of aortic conduit and reservoir function
  40. Unenhanced computed tomography as a diagnostic tool in suspected pulmonary hypertension: a retrospective cross-sectional pilot study
  41. Development and validation of AI-derived segmentation of four-chamber cine cardiac magnetic resonance
  42. Editorial for “Evaluation of Left Ventricular Flow Kinetic Energy by Four‐Dimensional Blood Flow MRI in Non‐Dialysis Chronic Kidney Disease Patients”
  43. Pulmonary transit time is a predictor of outcomes in heart failure: a cardiovascular magnetic resonance first-pass perfusion study
  44. Sex-specific cardiac magnetic resonance pulmonary capillary wedge pressure
  45. Noninvasive Techniques for Tracking Biological Aging of the Cardiovascular System
  46. A systematic review of artificial intelligence tools for chronic pulmonary embolism on CT pulmonary angiography
  47. Characterisation of the octogenarians presenting to the diagnostic heart failure clinic: SHEAF registry
  48. Validation of Left Atrial Volume Correction for Single Plane Method on Four-Chamber Cine Cardiac MRI
  49. Aortic flow is abnormal in HFpEF
  50. Validation of 2D flow MRI for helical and vortical flows
  51. 4D Flow Cardiac MR in Primary Mitral Regurgitation
  52. Four-dimensional flow assessment shows coronary artery flow reversal in severe aortic regurgitation
  53. Advancements in cardiac structures segmentation: a comprehensive systematic review of deep learning in CT imaging
  54. CMR characterization of patients with heart failure and left bundle branch block
  55. Deep learning based automated left ventricle segmentation and flow quantification in 4D flow cardiac MRI
  56. Occult coronary microvascular dysfunction and ischemic heart disease in patients with diabetes and heart failure
  57. Aortic flow is abnormal in HFpEF
  58. Comparison of Stress-Rest and Stress-LGE Analysis Strategy in Patients Undergoing Stress Perfusion Cardiovascular Magnetic Resonance
  59. Cardiac MR modelling of systolic and diastolic blood pressure
  60. The Left Atrial Area Derived Cardiovascular Magnetic Resonance Left Ventricular Filling Pressure Equation Shows Superiority over Integrated Echocardiography
  61. Hospitalization for permanent pacemaker implantation in the context of isolated sinus node dysfunction is associated with increased mortality compared with an outpatient strategy
  62. Cardiac Magnetic Resonance Left Ventricular Filling Pressure Is Associated with NT-proBNP in Patients with New Onset Heart Failure
  63. Restoration of flow in the aorta: a novel therapeutic target in aortic valve intervention
  64. Rationale and design of the United Kingdom Heart Failure with Preserved Ejection Fraction Registry
  65. P10 Defining cardiac MRI change thresholds based on how a patient feels, functions and survives post pulmonary arterial hypertension treatment
  66. Is it aortic stenosis or left ventricular outflow tract obstruction? The complementary role of four-dimensional flow cardiac magnetic resonance imaging
  67. Artificial Intelligence framework with traditional computer vision and deep learning approaches for optimal automatic segmentation of left ventricle with scar
  68. Corrigendum to: Aortic flow is associated with aging and exercise capacity
  69. Cardiac magnetic resonance left ventricular filling pressure is linked to symptoms, signs and prognosis in heart failure
  70. Comparison of Stress-rest and Stress-LGE analysis strategy in patients undergoing stress perfusion cardiovascular magnetic resonance
  71. Evidence-Based Consensus Recommendations for Skin Care in Healthy, Full-Term Neonates in India
  72. Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension
  73. Four-dimensional flow evaluation of left atrial myxoma-related mitral inflow
  74. Aortic flow is associated with aging and exercise capacity
  75. Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR
  76. Risk Factors Associated With Post−COVID-19 Condition
  77. 170 Non-invasive assessment of stroke work using cardiac magnetic resonance imaging
  78. 169 Two-dimensional and four-dimensional velocity imaging quantified mitral regurgitation is associated with left ventricular remodelling post mitral valve surgery
  79. Modelling The Hemodynamics of Coronary Ischemia
  80. An acute increase in Left Atrial volume and left ventricular filling pressure during Adenosine administered myocardial hyperaemia: CMR First-Pass Perfusion Study
  81. Mitral regurgitation quantification by cardiac magnetic resonance imaging (MRI) remains reproducible between software solutions
  82. Non-invasive detection of severe PH in lung disease using magnetic resonance imaging
  83. Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis
  84. Artificial Intelligence as a Diagnostic Tool in Non-Invasive Imaging in the Assessment of Coronary Artery Disease
  85. Deep learning-based prediction of intra-cardiac blood flow in long-axis cine magnetic resonance imaging
  86. Quantifying Myocardial Blood Flow and Resistance Using 4D-Flow Cardiac Magnetic Resonance Imaging
  87. Age- and sex-specific reference values of biventricular flow components and kinetic energy by 4D flow cardiovascular magnetic resonance in healthy subjects
  88. 4D Flow cardiovascular magnetic resonance consensus statement: 2023 update
  89. The Importance of Mitral Valve Prolapse Doming Volume in the Assessment of Left Ventricular Stroke Volume with Cardiac MRI
  90. Automated 4D flow cardiac MRI pipeline to derive peak mitral inflow diastolic velocities using short-axis cine stack: two centre validation study against echocardiographic pulse-wave doppler
  91. Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension
  92. Automatic development of 3D anatomical models of border zone and core scar regions in the left ventricle
  93. 33 Cardiac MRI thresholds for improvement in pulmonary arterial hypertension
  94. 8 Adverse cardiovascular outcomes in diabetic patients with heart failure are mediated by silent myocardial infarction
  95. Neonatologist-Performed Ultrasound-Guided Internal Jugular Vein Cannulation
  96. Cardiovascular magnetic resonance can improve the precision for left ventricular filling pressure assessment
  97. Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling
  98. Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction
  99. Validation of time-resolved, automated peak trans-mitral velocity tracking: Two center four-dimensional flow cardiovascular magnetic resonance study
  100. Fully automatic cardiac four chamber and great vessel segmentation on CT pulmonary angiography using deep learning
  101. Kat-ARC accelerated 4D flow CMR: clinical validation for transvalvular flow and peak velocity assessment
  102. Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction
  103. Editorial for “Corrected MRI Pulmonary Transit Time for Identification of Combined Pre and PostCapillary Pulmonary Hypertension in Patients With Left Heart Disease”
  104. Cardiovascular imaging techniques for the assessment of coronary artery disease
  105. The Role of Artificial Intelligence in Predicting Outcomes by Cardiovascular Magnetic Resonance: A Comprehensive Systematic Review
  106. Importance of cardiac magnetic resonance imaging assessment of left ventricular filling pressure at resting state
  107. Quality of reporting in AI cardiac MRI segmentation studies – A systematic review and recommendations for future studies
  108. Ultrasmall Superparamagnetic Particles of Iron Oxide and Cardiac Magnetic Resonance: Novel Imaging in Everyday Conditions
  109. Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
  110. The role of rivaroxaban in eosinophilic myocarditis
  111. Streamline-based three-dimensional peak-velocity tracing of transvalvular flow using four-dimensional flow cardiac magnetic resonance imaging for left ventricular diastolic assessment in aortic regurgitation: a case report
  112. Mitral regurgitation quantified by CMR 4D-flow is associated with microvascular obstruction post reperfused ST-segment elevation myocardial infarction
  113. Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
  114. Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications
  115. Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension
  116. Left ventricular four-dimensional blood flow distribution, energetics, and vorticity in chronic myocardial infarction patients with/without left ventricular thrombus
  117. Management of asymptomatic severe aortic stenosis: a systematic review and meta-analysis
  118. Validation of aortic valve pressure gradient quantification using semi-automated 4D flow CMR pipeline
  119. Imaging and Risk Stratification in Pulmonary Arterial Hypertension: Time to Include Right Ventricular Assessment
  120. CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension
  121. Valvular Cardiomyopathy: The Value of Cardiovascular Magnetic Resonance Imaging
  122. Mitral regurgitation quantification by cardiac magnetic resonance imaging (MRI) remains reproducible between software solutions
  123. Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension
  124. Rationale and clinical applications of 4D flow cardiovascular magnetic resonance in assessment of valvular heart disease: a comprehensive review
  125. Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements
  126. Ventricular flow analysis and its association with exertional capacity in repaired tetralogy of Fallot: 4D flow cardiovascular magnetic resonance study
  127. Transformer Based Feature Fusion for Left Ventricle Segmentation in 4D Flow MRI
  128. Echo planar imaging–induced errors in intracardiac 4D flow MRI quantification
  129. Sodium glucose co-transporter 2 inhibitors in heart failure with preserved ejection fraction: a systematic review and meta-analysis
  130. Four-dimensional flow cardiovascular magnetic resonance for the assessment of mitral stenosis
  131. Myocardial inflammation and energetics by cardiac MRI: a review of emerging techniques
  132. 19 Cardiac magnetic resonance to identify raised left ventricular filling pressure
  133. 16 Validation of time-resolved, automated peak transvalvular velocity tracking through the mitral valve using four-dimensional flow cardiovascular magnetic resonance
  134. Mitral regurgitation quantification by cardiac magnetic resonance imaging (MRI) remains reproducible between software solutions
  135. The importance of three dimensional coronary artery reconstruction accuracy when computing virtual fractional flow reserve from invasive angiography
  136. MA-SOCRATIS: An automatic pipeline for robust segmentation of the left ventricle and scar
  137. Mitral valve disease in sarcoidosis diagnosed by cardiovascular magnetic resonance
  138. A fully automated cardiac magnetic resonance (CMR) assessment improves the evaluation of patients with pulmonary arterial hypertension (PAH)
  139. The Role of SGLT2 Inhibitors in Heart Failure: A Systematic Review and Meta-Analysis
  140. Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis
  141. Cardiovascular examination using hand-held cardiac ultrasound
  142. Impact of age, sex and ethnicity on intra-cardiac flow components and left ventricular kinetic energy derived from 4D flow CMR
  143. Reproducibility of left ventricular blood flow kinetic energy measured by four-dimensional flow CMR
  144. Clinical Translation of Three-Dimensional Scar, Diffusion Tensor Imaging, Four-Dimensional Flow, and Quantitative Perfusion in Cardiac MRI: A Comprehensive Review
  145. Multicenter Consistency Assessment of Valvular Flow Quantification With Automated Valve Tracking in 4D Flow CMR
  146. Amplitude integrated EEG: how much it helps in prognostication in neonatal encephalopathy?
  147. Myocardial T1-mapping and extracellular volume in pulmonary arterial hypertension: A systematic review and meta-analysis
  148. Right Ventricular Adaptation Assessed Using Cardiac Magnetic Resonance Predicts Survival in Pulmonary Arterial Hypertension
  149. 172 Determining systematic bias in the assessment of left ventricular function between transthoracic echo and cardiac MRI using new generation imaging systems
  150. 26 The prognostic role of epicardial adipose tissue in aortic stenosis: insights from a cardiovascular magnetic resonance study
  151. Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in patients with atrial fibrillation
  152. Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis
  153. Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction
  154. Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension
  155. Standard and emerging CMR methods for mitral regurgitation quantification
  156. Detrimental Immediate- and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis
  157. Left ventricular blood flow kinetic energy is associated with the six-minute walk test and left ventricular remodelling post valvular intervention in aortic stenosis
  158. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
  159. SAUN: Stack attention U‐Net for left ventricle segmentation from cardiac cine magnetic resonance imaging
  160. Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study
  161. Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: A systematic review and meta-analysis
  162. Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
  163. Cardiovascular magnetic resonance imaging: emerging techniques and applications
  164. Characterisation of the patients with suspected heart failure: experience from the SHEAF registry
  165. Feasibility and validation of trans-valvular flow derived by four-dimensional flow cardiovascular magnetic resonance imaging in pacemaker recipients
  166. Meta‐analysis of echocardiographic quantification of left ventricular filling pressure
  167. Cardiac Magnetic Resonance in Pulmonary Hypertension—an Update
  168. Motivation for change in the health care of children with developmental disabilities: Pilot continuing professional development‐quality improvement project
  169. Left Ventricular Blood Flow Kinetic Energy Assessment by 4D Flow Cardiovascular Magnetic Resonance: A Systematic Review of the Clinical Relevance
  170. Sex bias exists in diagnosing pulmonary arterial hypertension via machine learning
  171. Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH
  172. Serial cardiac MRI for assessment of cardiac morphology and function in CTEPH patients after PEA or vasodilator therapy
  173. Feasibility and reproducibility of a cardiovascular magnetic resonance free-breathing, multi-shot, navigated image acquisition technique for ventricular volume quantification during continuous exercise
  174. Use of Point of Care Ultrasound for Confirming Central Line Tip Position in Neonates
  175. Prime time for handheld echocardiography in COVID-19 pandemic
  176. Validation of four-dimensional flow cardiovascular magnetic resonance for aortic stenosis assessment
  177. Age-associated changes in 4D flow CMR derived Tricuspid Valvular Flow and Right Ventricular Blood Flow Kinetic Energy
  178. Clinical predictors of all‐cause mortality in patients presenting to specialist heart failure clinic with raised NT‐proBNP and no heart failure
  179. Diagnostic accuracy of CT pulmonary angiography in suspected pulmonary hypertension
  180. A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis
  181. Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
  182. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging
  183. A prospective study comparing the repeatability and sensitivity to change of non-invasive endpoints in pulmonary arterial hypertension: the RESPIRE study
  184. Repeatability and Sensitivity to change of right ventricular analysis methods using cardiac magnetic resonance imaging in PAH: results from the RESPIRE Study
  185. Diagnostic accuracy of right ventricular trabecular mass measurements as measured on cardiac MRI in suspected pulmonary hypertension
  186. Regression of Left Ventricular Mass in Athletes Undergoing Complete Detraining Is Mediated by Decrease in Intracellular but Not Extracellular Compartments
  187. The Role of Cardiac MRI in the Management of Ventricular Arrhythmias in Ischaemic and Non-ischaemic Dilated Cardiomyopathy
  188. A Systematic Review of 4D-Flow MRI Derived Mitral Regurgitation Quantification Methods
  189. Intracardiac 4D Flow MRI in Congenital Heart Disease: Recommendations on Behalf of the ISMRM Flow & Motion Study Group
  190. Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial
  191. Normative Data of Optimally Placed Endotracheal Tube by Point-of-care Ultrasound in Neonates
  192. A Systematic Review of Right Ventricular Diastolic Assessment by 4D Flow CMR
  193. 26 A non-invasive CMR assessment for predicting mean pulmonary artery pressure in pulmonary hypertension
  194. Burden of adverse childhood experiences in children attending paediatric clinics in South Western Sydney, Australia: a retrospective audit
  195. 25 Mitral inflow velocity encoded imaging by CMR for the assessment of left ventricular haemodynamics
  196. 27 Mixed venous oxygen levels in pulmonary hypertension is associated with right heart multi-parametric assessment
  197. Clinical evaluation of two dark blood methods of late gadolinium quantification of ischemic scar
  198. Silent cerebral infarction and cognitive function following TAVI: an observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve
  199. Diagnosis of Pulmonary Hypertension with Cardiac MRI: Derivation and Validation of Regression Models
  200. Deep Learning–based Method for Fully Automatic Quantification of Left Ventricle Function from Cine MR Images: A Multivendor, Multicenter Study
  201. Feasibility study of a single breath-hold, 3D mDIXON pulse sequence for late gadolinium enhancement imaging of ischemic scar
  202. Impact of Age and Diastolic Function on Novel, 4D flow CMR Biomarkers of Left Ventricular Blood Flow Kinetic Energy
  203. CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome
  204. Left ventricular blood flow kinetic energy after myocardial infarction - insights from 4D flow cardiovascular magnetic resonance
  205. Left ventricular thrombus formation in myocardial infarction is associated with altered left ventricular blood flow energetics
  206. Early versus delayed cord clamping in small for gestational age infants and iron stores at 3 months of age - a randomized controlled trial
  207. Fully automated, inline quantification of myocardial blood flow with cardiovascular magnetic resonance: repeatability of measurements in healthy subjects
  208. Comparison of Image Acquisition Techniques in Four-Dimensional Flow Cardiovascular MR on 3 Tesla in Volunteers and Tetralogy of Fallot Patients
  209. CT derived left atrial size identifies left heart disease in suspected pulmonary hypertension: Derivation and validation of predictive thresholds
  210. 51 Assessment of cardiovascular response during continuous exercise using multi-shot, navigated, steady-state free precession cardiovascular magnetic resonance imaging: a pilot study of healthy controls
  211. 49 Reduced myocardial perfusion reserve in systolic heart failure a therapeutic target?
  212. 12 Cardiac effects of complete enforced detraining assessed by cardiovascular magnetic resonance
  213. 4 Four-dimensional left ventricular blood flow energetics independently predict adverse remodelling post st-elevation myocardial infarction
  214. 17 Single breath-hold, 3d mdixon pulse sequence for late gadolinium enhancement imaging of ischaemic scar: a feasibility study
  215. Cardiovascular magnetic resonance assessment of 1st generation CoreValve and 2nd generation Lotus valves
  216. High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey
  217. Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes
  218. Effects of hyperaemia on left ventricular longitudinal strain in patients with suspected coronary artery disease
  219. Role of Cardiac T1 Mapping and Extracellular Volume (ECV) in the Assessment of Myocardial Infarction
  220. Corrigendum to: Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial
  221. Clinical applications of intra-cardiac four-dimensional flow cardiovascular magnetic resonance: A systematic review
  222. Synthetic Myocardial Extracellular Volume Fraction
  223. Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial
  224. Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction
  225. Native T1 Mapping
  226. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure
  227. Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance ImagingCLINICAL PERSPECTIVE
  228. Post-procedural myocardial infarction following surgical aortic valve replacement and transcatheter aortic valve implantation
  229. 104 A service review and comparison of resource?utilisation with the change in recommendations from nice 2010 cg95 to the nice 2016update (chest pain of recent onset: assessment and diagnosis)
  230. THU0101 Cardiovascular magnetic resonance imaging characterisation of cardiovascular abnormalities in individuals at risk of developing rheumatoid arthritis
  231. 105 Differences in myocardial mechanics between ischaemic and non-ischaemic cardiomyopathy assessed by cmr: a sub-group analysis of the vindicate trial
  232. Comparison of fast acquisition strategies in whole-heart four-dimensional flow cardiac MR: Two-center, 1.5 Tesla, phantom and in vivo validation study
  233. The utility of global longitudinal strain in the identification of prior myocardial infarction in patients with preserved left ventricular ejection fraction
  234. 029 Diabetes, microalbuminuria and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure
  235. 026 Dimensional flow cardiovascular magnetic resonance: two-centre, 1.5t, phantom and in-vivo validation study
  236. The impact of trans-catheter aortic valve replacement induced left-bundle branch block on cardiac reverse remodeling
  237. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy
  238. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin
  239. Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality
  240. Myocardial strain and symptom severity in severe aortic stenosis: insights from cardiovascular magnetic resonance
  241. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review
  242. Right ventricular function following surgical aortic valve replacement and transcatheter aortic valve implantation: A cardiovascular MR study
  243. The role of left ventricular deformation in the assessment of microvascular obstruction and intramyocardial haemorrhage
  244. Chest Pain of Uncertain Aetiology: Role of Contrast Enhanced Computed Tomography in the Emergency Department
  245. A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes
  246. Relationship between cardiac deformation parameters measured by cardiovascular magnetic resonance and aerobic fitness in endurance athletes
  247. 42 Gender Differences in Response to Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis Assessed by Feature Tracking
  248. 38 Myocardial Infarction following Surgical and Trans-Catheter Aortic Valve Replacement – Is Peri-Procedural Revascularisation for TAVI Necessary?
  249. 40 Quantification of Aortic Regurgitation Following Transcatheter Aortic Valve Implantation (TAVI): A CMR Study of Two Prosthesis Designs
  250. 39 The Impact of New Left Bundle Branch Block Following Trans-Catheter Aortic Valve Impantation. Is There a TAVI LBBB-induced Cardiomyopathy? Insights from Cardiovascular Magnetic Resonance Imaging
  251. Advanced Analysis Techniques for Intra-cardiac Flow Evaluation from 4D Flow MRI
  252. Sex-related differences in left ventricular remodeling in severe aortic stenosis and reverse remodeling after aortic valve replacement: A cardiovascular magnetic resonance study
  253. Ventricular longitudinal function is associated with microvascular obstruction and intramyocardial haemorrhage
  254. Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete’s Heart
  255. 9 Global longitudinal strain using feature tracking identifies the presence of chronic myocardial infarction in patients with normal LV ejection fraction
  256. 11 Left ventricular end diastolic filling pressure predicted by left atrial strain measured by feature tracking
  257. 10 Quantitative myocardial perfusion and longitudinal strain by feature tracking in newly diagnosed, treatment naïve rheumatoid arthritis
  258. Acute Reverse Remodelling After Transcatheter Aortic Valve Implantation: A Link Between Myocardial Fibrosis and Left Ventricular Mass Regression
  259. Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass
  260. Noninvasive cardiac imaging in suspected acute coronary syndrome
  261. Diagnostic accuracy of Dixon water fat suppression coronary artery magnetic resonance angiography at 3.0 Tesla
  262. Post-procedural myocardial infarction following surgical and trans-catheter aortic valve replacement - mechanistic insights from cardiovascular magnetic resonance imaging
  263. Reliability and reproducibility of trans-valvular flow measurement by 4D flow magnetic resonance imaging in acute myocardial infarct patients: two centre study
  264. Imaging Aortic Regurgitation: The Incremental Benefit of Speckle Tracking Echocardiography
  265. Outcomes of Primary Percutaneous Coronary Intervention for Patients with Previous Coronary Artery Bypass Grafting Presenting with STsegment Elevation Myocardial Infarction
  266. Free-Wall Rupture Post–Reperfused Acute Myocardial Infarction
  267. Important role of myocardial tissue characterization by cardiac MRI in diagnosing Takotsubo syndrome
  268. Correction: Aerobic Capacity, Physical Activity and Metabolic Risk Factors in Firefighters Compared with Police Officers and Sedentary Clerks
  269. Aerobic Capacity, Physical Activity and Metabolic Risk Factors in Firefighters Compared with Police Officers and Sedentary Clerks
  270. Multiparametric relaxometry by cardiac magnetic resonance imaging in Takotsubo cardiomyopathy:
  271. 86 Abnormal Left Ventricular Geometry is Prevalent in Asymptomatic Patients with Established Rheumatoid Arthritis Compared with those with Early Disease and Healthy Controls
  272. 87 Dilatation of the Thoracic Aorta and Increased Arterial Stiffness is Common in Patients with Giant Cell Arteritis – Preliminary Findings from a Cardiac Magnetic Resonance Study
  273. 95 Left Ventricular Mass Regression Occurs very early following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis
  274. 97 Men and Women differ in their Adaptation to Aortic Stenosis and in Reverse Remodelling following Aortic Valve Intervention
  275. 85 Newly Diagnosed, Treatment-Naive Patients with Rheumatoid Arthritis have early Abnormalities of Vascular and Myocardial Function
  276. T-piece or self inflating bag for positive pressure ventilation during delivery room resuscitation: An RCT
  277. Relation of circumferential and longitudinal strain to other independent prognostic imaging markers in first time ST-elevation myocardial infarction
  278. 21 Left atrial remodelling following treatment of symptomatic severe aortic stenosis
  279. 16 Relationship of mitral annular plane systolic excursion and intra-myocardial haemorrhage in reperfused st-elevation myocardial infarction
  280. 22 Surgical aortic valve replacement (SAVR) upon right ventricular function: a cardiac mri study
  281. Imaging Tuberous Sclerosis: The Incremental Benefit of Three-Dimensional and Speckle Tracking Echocardiography
  282. Defining non-valvular atrial fibrillation while selecting anticoagulation therapy
  283. Incidental Extra-Cardiac Findings in CMR
  284. Mitral annular plane systolic excursion and intra-myocardial haemorrhage in acute myocardial infarction
  285. Assessment of interventricular systolic relationship and infarct location in acute myocardial infarction
  286. A comparison of dual-bolus and dual-sequence quantitative myocardial perfusion techniques
  287. Echocardiographic Evaluation of Left Atrial Mechanics: Function, History, Novel Techniques, Advantages, and Pitfalls
  288. Is signal intensity of late gadolinium enhancement a substitute for extracellular volume mapping in acute myocardial infarction?
  289. CMR assessment of longitudinal left ventricular function following transcatheter aortic valve implantation (TAVI) for severe aortic stenosis
  290. Split dose versus single bolus gadolinium administration in ecv calculation at 3 tesla cmr
  291. Gender influences left ventricular remodelling in the setting of aortic stenosis but does not appear to impact on reverse remodelling following transcatheter aortic valve implantation
  292. Newly diagnosed, treatment-naive patients with rheumatoid arthritis have early abnormalities of vascular and myocardial function
  293. Left ventricular mass regression may occur very early following transcatheter aortic valve implantation for severe aortic stenosis
  294. Cardiovascular magnetic resonance assessment of ventricular morphology to investigate the mechanisms of heart failure associated with type 2 diabetes
  295. Left atrial remodelling following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR)
  296. The prognostic value of cardiovascular magnetic resonance in aborted sudden cardiac death
  297. Abnormal left ventricular geometry is prevalent in asymptomatic patients with established rheumatoid arthritis compared with those with early disease and healthy controls
  298. Dilatation of the thoracic aorta and increased arterial stiffness is common in patients with giant cell arteritis - preliminary findings from a cardiac magnetic resonance study
  299. Right ventricular function following Surgical Aortic Valve Replacement (SAVR)
  300. T2-mapping and T2*-mapping for detection of intramyocardial haemorrhage: a head-to-head comparison with T2-weighted imaging
  301. Pretransfusion Comparison of Dialyser-Based Hemoconcentrator With Cell Saver System for Perioperative Cell Salvage
  302. A Framework for Developing a Curriculum Regarding Autism Spectrum Disorders for Primary Care Providers
  303. Neonatal Repair of Common Arterial Trunk With Intact Ventricular Septum
  304. Brugada syndrome unmasked by ischemia needs full risk evaluation: author’s reply
  305. Correction
  306. Is this ST-elevation because of myocardial ischaemia or a Brugada pattern? An interesting case review
  307. Prosthetic mitral valve tamponade alternans
  308. Successful late brachial artery embolectomy using Swan Ganz catheter—a case report
  309. Non-vitamin K antagonist oral anticoagulants (NOACs): clinical evidence and therapeutic considerations
  310. Hypertensive Emergency and Type 2 Myocardial Infarction Resulting From Pheochromocytoma and Concurrent Capnocytophaga Canimorsus Infection
  311. Type F Congenital Quadricuspid Aortic Valve: A Very Rare Case Diagnosed by 3-dimenional Transoesophageal Echocardiography
  312. Valve in Valve: Three-Dimensional Transoesophageal Echocardiogram and Multi-Slice CT Images of Bio-Prosthetic Aortic Valve Replaced by Medtronic CoreValve
  313. An Exploratory Survey for Understanding Perceptions, Knowledge and Educational Needs of General Practitioners (GSs) Regarding Autistic Disorders in New South Wales (NSW), Australia
  314. Variability of thinness and its relation to cardio-metabolic risk factors using four body mass index references in school-children from Delhi, India
  315. Oxygen therapy in patients with chest pain of acute onset: single centre audit experience
  316. Cardiology day case unit: the way to manage chronic cardiovascular conditions cost-effectively in future
  317. Oxygen therapy in acute coronary syndrome: current NICE recommendations
  318. Cardiac involvement in systemic lupus erythematosus not only limited to pericarditis
  319. Cardiology a ward rounds: rationale of using a checklist
  320. Towards universal health coverage in India
  321. Acute decompensated heart failure secondary to thiamine deficiency: often a missed diagnosis
  322. Impact on service provision for non-invasive cardiac imaging following NICE recommendations: an observational study
  323. Public-private collaboration: way forward for survival in resource-poor settings
  324. Aggressive Cardiac Involvement in Systemic Lupus Erythematosus: A Case Report and a Comprehensive Literature Review
  325. Calcified Left Ventricular Aneurysm: “An Egg in the Heart”
  326. Use of the Joint British Society cardiovascular risk calculator before initiating statins for primary prevention in hospital medicine: experience from a large university teaching hospital
  327. Pericardial effusion – forgotten differential diagnosis of shortness of breath
  328. Intravascular Ultrasound and Angiographic Demonstration of Left Main Stem Thrombus—High-risk Presentation in a Young Adult with Anabolic Steroid Abuse
  329. Gender Bias in Critically Sick Newborns and Young Infants: An Ethical Dilemma?